期刊文献+
任意字段
题名或关键词
题名
关键词
文摘
作者
第一作者
机构
刊名
分类号
参考文献
作者简介
基金资助
栏目信息

新型催眠药物suvorexant

下载PDF
导出
摘要 Suvorexant是一种食欲素受体拮抗药,可影响食欲素通路的信号传导,有效调节睡眠-觉醒周期,是首个被美国食品药品管理局(FDA)批准用于治疗入睡困难及睡眠维持困难的食欲素受体拮抗药类催眠药。其有效性和安全性已经得到临床试验的支持,结合其独特的作用机制、低成瘾性等优势,suvorexant展现出可观的应用前景。
作者 闫荟羽 宋燕青 苗秋丽 张四喜
机构地区 吉林大学第一医院药品管理部
出处 《医药导报》 CAS 2016年第3期282-284,共3页 Herald of Medicine
关键词 suvorexant 食欲素受体拮抗药 失眠症 催眠药
分类号 R971.3 [医药卫生—药品]
  • 相关文献

参考文献12

  • 1OHAYON M M. Epidemiology of insomnia: what we know and what we still need to learn [ J ]. Sleep Med Rev, 2002,6 (2) :97-111.
  • 2U S Food and Drug Administration.FDA approves new type of sleep drug, Belsomra [ EB/OL] [ 2014-09-14]. http:// www. fda. gov/NewsEvents/Newsroom/Press Announce- ments/ucm409950.htm.
  • 3MICHELSON D, SNYDER E, PARADIS E, et al.Safety and efficacy of suvorexant during 1-year treatment of insomnia with sabseqnent abrupt treatment discontinuation :a phase 3randomised, double-blind, placebo-controlled trim [ J ]. Lan- cet Neurol, 2014,13 (5) : 461-471.
  • 4ZEITZER J M, NISHINO S, MIGNOT E.The neurobiology of hypocretins ( orexins), narcolepsy and related therapeutic interventions [ J ] .Trends Pharmacol Sci, 2006,27 (7) : 368- 374.
  • 5CITROME L.Suvorexant for insomnia: a systematic review of the efficacy and safety profile for this newly approved hypnotic-what is the number needed to treat, number nee- ded to harm, and likelihood to be helped or harmed? [ J ]. Int J Clin Praet,2014,68(12) : 1429-1441.
  • 6Merck Sharp & Dohme Corporatign,Whitehouse Station.Su- vorexant Advisory Committee Meeting Briefing Document [ EB/OL ]. [ 2013 - 05 - 22 ]. http ://www. fda. gov/down- loads/advisoryeommittees/eommittees meeting materials/ drugs/peripheraland central nervoussystem drugs advisory committee/ucm352970.pdf".
  • 7PATEL K V,ASPESI A V,EVOY K E.Suvorexant: a dual orexin receptor antagonist for the treatment of sleep onset and sleep maintenance insomnia [ J ]. Ann Pharmacothera- py,2015,49(4) : 1-7.
  • 8HERRING J W,SNYDER E,BUDD K,et al.Orexin recep- tor antagonism for treatment of insomnia: a randomized clinical trial of suvorexant [ J ]. Neurology, 2012,79 ( 23 ) : 2265-2274.
  • 9SUN H, KENNEDY W P, DARREN W,et al.Effects of suv- orexant, an orexin receptor antagonist, on sleep parameters as measured by polysomnography in healthy men[ J ] .Sleep, 2013,36(2) :259-267.
  • 10SCHUTrE-RODIN S, BROCH L, BUYSSE D, et al M. Clini- cal guideline for the evaluation and management of chronic insomnia in adults [ J ].J Clin Sleep Med, 2008,4 ( 5 ) : 487 - 504.
医药导报
2016年 第3期

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部